The influence of organizational stigmatization on legitimacy claims in CSR disclosures

Harsh Jha, Andrew Kozhevnikov, B Liu

Research output: Chapter in Book/Report/Conference proceedingConference proceedingpeer-review


This paper explores the undertheorized relationship between organizational stigma and corporate reputation, specifically how legitimate accounts are constructed in CSR disclosures in order to enhance corporate reputation, when facing episodes of intense stigma. Following single case study method, we qualitatively examine fourteen CSR reports released by the leading pharmaceutical firm GSK during the period of 2002-2015. Then, we analyse the influence of three episodes of intense stigmatization faced by GSK – Paxil, Avandia and China bribery scandals – on the salience of various themes induced from CSR reports. Our findings suggest that increase in intensity of public stigmatization of a firm may have a positive influence on the variety of themes included in CSR disclosures, targeting various bases of legitimacy – regulatory, associational and moral, and increase in dominance of moral legitimacy claims, over time.
Original languageEnglish
Title of host publicationAcademy of Management Annual Meeting Proceedings
PublisherAcademy of Management
Publication statusPublished - 1 Aug 2018
Event78th Annual Meeting of the Academy of Management: Improving Lives - Chicago, United States
Duration: 10 Aug 201814 Aug 2018
Conference number: 78


Conference78th Annual Meeting of the Academy of Management
Abbreviated title2018 AOM Annual Meeting
Country/TerritoryUnited States
Internet address


Dive into the research topics of 'The influence of organizational stigmatization on legitimacy claims in CSR disclosures'. Together they form a unique fingerprint.

Cite this